Mangoceuticals MGRX Growth Metrics (2023-2026)

NASDAQ MGRX
$0.20 +0.01 (+5.26%)
At close: Nov 9, 2026 · 4:00 PM EST
Reported Financials

Mangoceuticals Quarterly Growth Metrics

Periods 14 quarters
Latest Jun 2026

Mangoceuticals reported revenue growth of -21.33% and asset growth of 62.60% for the quarter ended Jun 2026. These growth metrics cover 14 quarters of results from Mar 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Total Debt (QoQ) 114.29%0.00%-20.00%-83.33%
Total Debt Growth (1y) 220.00%-46.67%-92.51%
Share-based Compensation (QoQ)Stock Comp. (QoQ) -90.82%4.00%436.94%16.05%94.09%-43.27%-7.82%358.55%63.79%74.58%-98.92%1,716.86%-98.86%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y) 15.91%-42.19%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) -40.50%1,157.80%586.12%17.79%365.43%292.76%1,108.66%-85.81%-43.77%-99.61%
Revenue (QoQ) 40.22%73.58%-0.32%-12.39%-23.79%-18.26%-21.09%3.86%53.80%-49.89%12.01%-28.08%1.32%
Revenue Growth (3y) -12.33%-21.33%
Revenue Growth (1y) 112.56%15.52%-45.60%-56.93%-48.95%3.03%-36.83%-10.34%-37.91%-59.10%
Return on Sales [ROS] (QoQ)ROS (QoQ) 0.09M0.09M-0.03M-0.01M-0.02M0.00M-0.03M-0.26M0.11M-0.58M0.86M-0.42M0.31M
Return on Sales [ROS] Growth (3y)ROS Growth (3y) -0.21M0.01M
Return on Sales [ROS] Growth (1y)ROS Growth (1y) 0.14M0.03M-0.06M-0.05M-0.31M-0.18M-0.76M0.12M-0.04M0.16M
Return on Equity [ROE] (QoQ)ROE (QoQ) 0.01M474.00-268.00-655.000.00M0.00M-48.000.00M
Return on Equity [ROE] Growth (1y)ROE Growth (1y) 0.08M0.01M0.00M-0.01M-0.01M0.00M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) 0.01M667.00-130.00-774.000.00M-853.00294.000.00M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) 0.08M0.01M0.00M-0.01M-0.01M0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ) -0.06M0.12M0.01M438.00-249.00-646.000.00M0.00M78.000.00M
Return on Assets [ROA] Growth (1y)ROA Growth (1y) 0.06M0.13M0.01M0.00M-0.01M-0.01M0.00M
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) -2.18%-5.42%-5.79%-6.14%-6.47%-96.31%-7.61%-8.33%-8.91%-9.86%-11.07%-12.45%-13.94%-16.32%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y) -75.19%-76.23%-77.18%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) -18.19%-21.78%-96.95%-97.01%-97.08%-97.16%-30.46%-33.06%-36.07%-39.59%-43.92%
Operating Margin (QoQ) 0.09M0.09M-0.03M-0.01M-0.02M0.00M-0.03M-0.26M0.11M-0.58M0.86M-0.42M0.31M
Operating Margin Growth (3y) -0.21M0.01M
Operating Margin Growth (1y) 0.14M0.03M-0.06M-0.05M-0.31M-0.18M-0.76M0.12M-0.04M0.16M
Operating Income (QoQ)Op. Inc (QoQ) 10.43%21.50%-42.71%7.80%8.40%18.93%4.57%-172.78%-15.12%-43.17%95.12%-750.15%66.96%
Operating Income Growth (3y)Op. Inc Growth (3y) -6.90%23.33%
Operating Income Growth (1y)Op. Inc Growth (1y) 7.48%5.39%2.30%34.67%-93.29%-142.94%-329.04%78.08%31.69%80.39%
Net Margin (QoQ) 0.09M0.09M-0.03M-0.01M-0.04M-0.03M-0.01M-0.28M0.13M-0.60M0.61M-0.22M0.31M
Net Margin Growth (3y) -0.29M-0.07M
Net Margin Growth (1y) 0.14M0.02M-0.10M-0.08M-0.36M-0.19M-0.77M-0.14M-0.08M0.11M
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) 10.81%21.22%-42.71%7.81%-0.99%4.09%15.04%-163.47%-11.23%-38.57%61.28%-20.68%56.54%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y) -13.02%11.06%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) 7.55%-4.68%-27.44%24.13%-116.82%-138.81%-245.02%-57.24%27.98%71.86%
Net Income (QoQ) 10.81%21.22%-42.71%7.80%-1.00%16.38%2.56%-148.36%-11.91%-40.68%63.65%-22.89%61.42%
Net Income Growth (3y) -9.94%16.85%
Net Income Growth (1y) 7.55%-4.70%-11.13%24.12%-104.40%-126.48%-281.00%-42.12%29.68%75.76%
Net Cash Flow (QoQ)NCF (QoQ) -128.97%-85.24%70.91%-45.38%156.80%-201.17%98.30%244.40%138.14%1,462.73%164.45%-230.39%80.13%
Net Cash Flow Growth (3y)NCF Growth (3y) -34.10%34.42%
Net Cash Flow Growth (1y)NCF Growth (1y) -122.70%144.51%75.69%98.58%101.41%-94.08%191.46%14,311.36%-12,932.40%-1,170.46%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ) 27.32%59.04%81.19%
Income After Tax (QoQ) 10.81%21.22%-42.71%7.80%-1.00%16.38%2.56%-148.36%-11.91%-40.68%63.65%-22.89%61.42%
Income After Tax Growth (3y) -9.94%16.85%
Income After Tax Growth (1y) 7.55%-4.70%-11.13%24.12%-104.40%-126.48%-281.00%-42.12%29.68%75.76%
Gross Profit (QoQ) 52.33%65.95%-1.39%3.38%-52.65%18.45%-3.11%-22.52%44.93%-43.41%-6.73%-38.91%52.46%
Gross Profit Growth (3y) -20.26%-20.24%
Gross Profit Growth (1y) 157.69%-19.90%-42.82%-43.82%-57.89%28.88%-38.43%-40.73%-53.27%-50.84%
Gross Margin (QoQ) 490.00-271.00-63.000.00M0.00M0.00M0.00M0.00M-327.00691.000.00M-758.000.00M
Gross Margin Growth (3y) 0.00M262.00
Gross Margin Growth (1y) 0.00M0.00M301.000.00M0.00M0.00M-157.000.00M0.00M0.00M
Free Cash Flow (QoQ)FCF (QoQ) 1.72%3.92%0.76%41.62%-59.13%26.08%3.11%-101.38%44.77%1.21%13.17%-21.67%80.13%
Free Cash Flow Growth (3y)FCF Growth (3y) 10.22%47.31%
Free Cash Flow Growth (1y)FCF Growth (1y) 45.30%11.42%31.85%33.47%-129.51%20.34%-6.47%4.59%42.35%79.27%
FCF Margin (QoQ) 0.05M0.06M308.000.02M-0.05M0.01M-0.02M-0.10M0.13M-0.07M0.03M-0.08M0.16M
FCF Margin Growth (3y) -0.01M0.09M
FCF Margin Growth (1y) 0.13M0.03M-0.02M-0.04M-0.16M0.02M-0.06M-0.01M0.01M0.04M
EPS (Diluted) (QoQ) 36.34%21.96%-41.03%34.94%11.65%17.13%13.54%-13.52%48.83%-20.04%55.70%26.25%58.16%
EPS (Diluted) Growth (3y) 59.64%64.91%
EPS (Diluted) Growth (1y) 54.41%36.74%32.82%58.82%28.14%58.38%39.71%69.10%79.93%83.59%
EPS (Basic) (QoQ) 36.34%21.96%-41.03%34.94%11.65%17.13%13.54%-13.52%48.83%-20.04%55.70%26.25%58.16%
EPS (Basic) Growth (3y) 59.64%64.91%
EPS (Basic) Growth (1y) 54.41%36.74%32.82%58.82%28.14%58.38%39.71%69.10%79.93%83.59%
EBT (QoQ) 10.81%21.22%-42.71%7.80%-1.00%16.38%2.56%-148.36%-11.91%-40.68%63.65%-22.89%61.42%
EBT Margin (QoQ) 0.09M0.09M-0.03M-0.01M-0.04M0.00M-0.04M-0.26M0.12M-0.58M0.61M-0.21M0.31M
EBT Margin Growth (3y) -0.25M-0.03M
EBT Margin Growth (1y) 0.14M0.02M-0.08M-0.08M-0.33M-0.18M-0.75M-0.11M-0.06M0.13M
EBT Growth (3y) -9.94%16.85%
EBT Growth (1y) 7.55%-4.70%-11.13%24.12%-104.40%-126.48%-281.00%-42.12%29.68%75.76%
EBIT (QoQ) 10.43%21.50%-42.71%7.80%8.40%18.93%4.57%-172.78%-15.12%-43.17%95.12%-750.15%66.96%
EBIT Margin (QoQ) 0.09M0.09M-0.03M-0.01M-0.02M0.00M-0.03M-0.26M0.11M-0.58M0.86M-0.42M0.31M
EBIT Margin Growth (3y) -0.21M0.01M
EBIT Margin Growth (1y) 0.14M0.03M-0.06M-0.05M-0.31M-0.18M-0.76M0.12M-0.04M0.16M
EBIT Growth (3y) -6.90%23.33%
EBIT Growth (1y) 7.48%5.39%2.30%34.67%-93.29%-142.94%-329.04%78.08%31.69%80.39%
EBITDA Margin (QoQ) 0.09M0.09M-0.03M-0.01M-0.02M0.00M-0.03M-0.23M0.10M-0.64M0.96M-0.45M0.31M
EBITDA Margin Growth (3y) -0.17M0.05M
EBITDA Margin Growth (1y) 0.14M0.03M-0.06M-0.05M-0.28M-0.16M-0.79M0.19M-0.03M0.18M
Cash from Operations (QoQ)Cash from Ops. (QoQ) 1.53%3.92%0.76%41.62%-59.13%26.08%3.11%-101.38%44.77%1.21%13.17%-21.67%80.13%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y) 10.16%47.31%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) 45.19%11.42%31.85%33.47%-129.51%20.34%-6.47%4.59%42.35%79.27%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) -40.25%-97.93%3,103.16%-84.92%-20.64%30.42%32.06%376.43%208.83%-88.26%31.01%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) 29.60%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 8.22%-94.02%-92.06%399.81%-79.39%551.15%2,434.12%128.20%126.38%
Assets (QoQ) 310.18%-19.89%-51.60%-34.14%-71.31%4,954.89%-2.93%3.91%41.53%-4.19%-20.68%-2.68%-10.20%-1.91%
Assets Growth (3y) 152.18%51.99%62.60%
Assets Growth (1y) 4.74%-92.67%362.23%827.11%1,362.75%7,116.48%36.78%11.76%4.68%-33.58%-32.00%

Mangoceuticals Growth Metrics API

Pull Mangoceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MGRX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY